遗忘关节评分是全踝关节置换术的有效结局指标:一项前瞻性研究
本研究前瞻性纳入120例接受三组件全踝关节置换术的患者,评估意大利语版遗忘关节评分(FJS)的信度、效度、反应度及地板天花板效应。结果显示FJS内部一致性(Cronbach α=0.95)和重测信度(ICC=0.99)优异,与AOFAS、MOXFQ、VAS强相关,6至12个月反应度Cohen d=0.37,6个月和12个月天花板/地板效应均低于15%阈值,未发现性别与结局的关联。
要点
- FJS在TAA患者中显示优异的内部一致性(Cronbach α=0.95)和重测信度(ICC=0.99)。
- FJS与AOFAS、MOXFQ、VAS强相关(Pearson和Spearman值持续高于0.7或低于-0.7)。
- 6个月和12个月天花板/地板效应分别为4%/3%和10%/0%,低于推荐的15%可解释性阈值。
核心结论
- FJS在接受全踝关节置换术的患者中测试性能和效度强,似乎适合临床使用,但未来研究应在其他患者人群中重复或反驳本研究发现。
研究设计与样本
- 前瞻性观察性研究,纳入2021年6月至2023年5月在本机构接受全踝关节置换术的患者,采用前路三组件假体。
- 共120例患者(平均年龄62±10岁)参与,占符合条件者的83%(120/145),其中77%(92/120)在术后12±1个月完成随访评估。
- 使用经跨文化适应和验证的意大利语版遗忘关节评分(FJS),同时施测AOFAS踝-后足评分、MOXFQ和VAS。
主要发现
- 信度:内部一致性优异(Cronbach α系数=0.95),重测信度优异(组内相关系数=0.99;测量标准误=2.7)。
- 效度:FJS与AOFAS踝-后足评分、MOXFQ和VAS强相关(Pearson和Spearman值持续高于0.7或低于-0.7)。
- 反应度:6至12个月间观察到反应度(Cohen d=0.37)。
- 天花板和地板效应低:6个月时分别有4%和3%达到最高分和最低分,12个月时分别有10%和0%达到最高分和最低分,均低于推荐的15%可解释性阈值。
- 未观察到结局与患者性别之间的关联。
关键数值与推荐
- 内部一致性Cronbach α系数=0.95。
- 重测信度组内相关系数=0.99;测量标准误=2.7。
- 6个月天花板效应4%、地板效应3%;12个月天花板效应10%、地板效应0%,均低于推荐的15%可解释性阈值。
- 6至12个月反应度Cohen d=0.37。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来研究应在其他患者人群中重复或反驳本研究发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The success of total ankle arthroplasty (TAA) involves objective and subjective parameters such as joint motion and implant survival. Patient-reported outcome measures provide key context from the patient's perspective so that we can evaluate the results of these procedures. The Forgotten Joint Score (FJS) has demonstrated validity and reliability in other arthroplasties, but the existing evidence on the FJS in TAA is very limited. QUESTION/PURPOSES: We aimed to assess the reliability, validity, responsiveness to change, and floor and ceiling effects, as well as to perform a gender analysis, of the FJS in patients who had undergone TAA. METHODS: A prospective, observational study enrolled patients who underwent TAA at our institution between June 2021 and May 2023. The three-component TAA was performed through an anterior approach. A total of 120 patients (mean age 62 ± 10 years) participated, which was 83% (120 of 145) of those eligible, and 77% (92 of 120) of those patients underwent follow-up assessments at 12 ± 1 months after surgery. A cross-culturally adapted and validated version of the FJS in our language (Italian) was used. Additionally, three other commonly used patient-reported outcome measures for TAA were administered: the American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score, the Manchester-Oxford Foot Questionnaire (MOXFQ), and the VAS. RESULTS: Reliability was demonstrated by excellent internal consistency (Cronbach α coefficient = 0.95) and excellent test-retest reliability (intraclass correlation coefficient = 0.99; standard error of measurement = 2.7). Robust validity was observed, in that the FJS had a strong correlation with the AOFAS ankle-hindfoot score, the MOXFQ, and the VAS (Pearson and Spearman values consistently above 0.7 or below -0.7). Responsiveness to change was observed between 6 and 12 months (Cohen d = 0.37). Low ceiling and floor effects at both 6 months (4% and 3% reached top and bottom scores, respectively) and 12 months (10% and 0% reached top and bottom scores, respectively) were demonstrated, below the recommended 15% interpretability threshold. No association between outcomes and patient gender was observed. CONCLUSION: Test properties and validity of the FJS were strong in patients who underwent TAA. It seems suitable for clinical use, although future studies should seek to replicate or refute our findings in other patient populations. LEVEL OF EVIDENCE: Level II, therapeutic study.
引用
- Mazzotti A, Zielli SO, Artioli E, et al. The Forgotten Joint Score Is a Valid Outcome Measure for Total Ankle Arthroplasty: A Prospective Study. Clin Orthop Relat Res. 2024. PMID: 38686993. doi:10.1097/CORR.0000000000003083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。